Instagram 20profile 20picture
Twitter 20profile 20picture

Drive Therapeutics

Addressing Unmet Patient Needs in Retinal Disease

  • Stage Product In Development
  • Industry Biotechnology
  • Location Chapel Hill, NC, USA
  • Currency USD
  • Founded November 2019
  • Employees 3
  • Incorporation Type LLC
  • Website drivetherapeutics.com

Company Summary

Drive Therapeutics, LLC, has developed stable, non-immunogenic, candidate molecules against a number novel targets in the progression of retinal diseases. These molecules can be used by themselves or in conjunction with existing therapies to achieve greater therapeutic efficacy while reducing the dosing regimen, resulting in better patient outcomes.

Team

  • 89cb7c1e 82b6 43a3 9b04 b78980d57055
    Ryan Quick
    Co-founder, COO

    Small business owner and experienced leader in large and small scale aptamer manufacturing and analytical
    Formerly, Head of Research Chemistry, Vitrisa Therapeutics
    Director of Analytical Development and Validation, Novan

  • 999d7ed4 13f1 4758 8492 f4f4c97d4ea3
    Matthew Levy
    Co-founder, CSO

    Expert in aptamer development and translation
    Formerly, Head of Discovery, Vitrisa Therapeutics
    Assoc. Prof. of Biochemistry, Albert Einstein College of Medicine

Advisors